Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) was the target of a large decline in short interest in May. As of May 15th, there was short interest totalling 13,800 shares, a decline of 42.5% from the April 30th total of 24,000 shares. Approximately 0.0% of the shares of the stock are sold short. Based […]
Achilles Therapeutics plc (NASDAQ:ACHL – Get Free Report) saw a significant drop in short interest in the month of May. As of May 15th, there was short interest totalling 13,800 shares, a drop of 42.5% from the April 30th total of 24,000 shares. Based on an average daily trading volume, of 396,500 shares, the short-interest […]
enGene (NASDAQ:ENGN) Shares Down 5.7% dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) CEO Sushil Patel sold 20,194 shares of the company’s stock in a transaction on Thursday, May 16th. The shares were sold at an average price of $6.47, for a total value of $130,655.18. Following the completion of the sale, the chief executive officer now owns 212,014 shares […]
Shares of enGene Holdings Inc. (NASDAQ:ENGN – Get Free Report) dropped 5.7% during trading on Wednesday . The stock traded as low as $12.52 and last traded at $12.52. Approximately 821 shares were traded during trading, a decline of 98% from the average daily volume of 53,480 shares. The stock had previously closed at $13.27. […]